Stakeholders analysis of merging social health insurance funds in Iran: what kind of interests they may gain or lose?

The International Journal of Health Planning and Management
Mohammad BazyarAlireza Olyaeemanesh

Abstract

Iran passed a Law in 2010 to merge all existing health insurance funds physically together. This stakeholder analysis aimed at revealing that what benefits the stakeholders might lose or gain as a result of merging health insurance schemes in Iran, which make them to oppose or support it. This was a qualitative study conducted in 2014. Sixty semi-structured face-to-face interviews were conducted. Purposive and snowball samplings with maximum heterogeneity samples were used for selecting interviewees. Government is not willing to undertake more financial commitment. Existing health insurance schemes like Social Security Organization and minor well-resourced health insurance funds and also worker unions are unwilling to lose their financial and organizational autonomy, to share their benefits with other less privileged groups, or face likely financial challenges in running their health facilities like hospitals. Top managers and workforces are worried to lose their job, salary, or organizational positions. Ministry of Cooperation, Labour, and Social Welfare does not want to lose its control on health insurance schemes. Ministry of Health and Medical Education and Iran Health Insurance Organization are among actors that support th...Continue Reading

References

Jul 1, 1994·Journal of Substance Abuse Treatment·K J Miller
Aug 19, 1993·The New England Journal of Medicine·D F Thompson
Sep 1, 1996·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·B C Nelms
Jan 8, 1998·The New England Journal of Medicine·H T StelfoxA S Detsky
Jan 1, 1995·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·A F Coburn, K J Mueller
Nov 30, 2000·The New England Journal of Medicine·S V McCraryB A Brody
Mar 23, 2004·Health Policy·Supasit PannarunothaiSamrit Srithamrongsawat
Mar 1, 1950·American Journal of Public Health and the Nation's Health·M C KLEM
Feb 11, 2005·Applied Health Economics and Health Policy·Richard D Smith
Apr 26, 2006·Social Science & Medicine·Hong WangWilliam Hsiao
Feb 7, 2009·Bulletin of the World Health Organization·Siriwan Pitayarangsarit, Viroj Tangcharoensathien
May 1, 2010·HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues·Andrea Frolic, Paula Chidwick
May 1, 2010·HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues·Andrea Frolic, Paula Chidwick
Jun 12, 2010·Bulletin of the World Health Organization·David B Evans, Carissa Etienne
Feb 10, 2011·Health Policy and Planning·Hossein IbrahimipourReza Dehnavieh
Jan 27, 2012·Health Policy and Planning·Zahra KavosiMohammad Arab
Jun 2, 2012·Health Policy·Fevzi AkinciFatma Oğücü
Sep 4, 2012·BMC Health Services Research·Sara JavanparastGholamreza Heidari
Feb 16, 2013·Health Policy and Planning·Mahmut S YardimNazan Yardim
May 2, 2013·Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees·Péter Kakuk, Andrea Domján
Jul 3, 2013·Lancet·Rifat AtunRecep Akdağ
Dec 18, 2013·Health Policy and Planning·Svetlana Ancker, Bernd Rechel
May 31, 2016·International Journal of Health Policy and Management·Mohammad BazyarLeila Doshmangir
May 1, 2018·The Journal of Pediatrics·JoAnna K LeyenaarPeter K Lindenauer

❮ Previous
Next ❯

Citations

Sep 20, 2019·BMC Health Services Research·Leila DoshmangirAbraham Assan
Jan 10, 2020·BMC Health Services Research·Mohammad BazyarLeila Doshmangir
Aug 6, 2020·ClinicoEconomics and Outcomes Research : CEOR·Leila DoshmangirEsmaeil Moshiri
May 10, 2020·Archives of Iranian Medicine·Leila DoshmangirFarshad Farzadfar
Jan 16, 2021·International Journal for Equity in Health·Leila DoshmangirVladimir Sergeevich Gordeev

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved